Stemtech Corporation (STEK) develops and distributes stem cell nutrition and stemceutical wellness products, including plant-based nutritional supplements, skin care and oral care products. Its updates commonly cover product availability, inventory funding, the Stemtech BioSciences e-commerce retail channel, and the company's network marketing model built around Independent Business Partners.
Company news also addresses scientific and advisory appointments, regulatory alignment for global wellness products, and international distribution initiatives through subsidiaries and joint ventures in markets such as India and the Gulf Cooperation Council region. Stemtech operates as a Nevada public company that became publicly traded in 2021 after continuing operations under new leadership in 2018.
Stemtech Corporation (OTC:STEK), a leader in stem cell nutrition, has officially changed its corporate name and ticker symbol. The change, announced on FINRA’s Daily List, reflects the company’s heritage and growth over 16 years. Stemtech specializes in plant-based nutritional supplements that aid in stem cell release and support immune health. The company is committed to maintaining its leadership in the nutraceutical sector, continuing to innovate and develop patented products. For ongoing updates, investors can consult the company’s website.